Privia Health Group, Inc. (NASDAQ:PRVA) Receives $25.07 Consensus Target Price from Brokerages

Privia Health Group, Inc. (NASDAQ:PRVA) has earned an average rating of “Buy” from the sixteen ratings firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, twelve have assigned a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $25.07.

PRVA has been the topic of several recent analyst reports. KeyCorp assumed coverage on Privia Health Group in a research note on Friday, October 11th. They set an “overweight” rating and a $23.00 target price on the stock. Barclays increased their price objective on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Friday, November 8th. Truist Financial boosted their target price on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. Finally, Robert W. Baird lifted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 26th.

Privia Health Group Stock Performance

Shares of Privia Health Group stock opened at $21.18 on Tuesday. The company has a 50-day simple moving average of $18.91 and a two-hundred day simple moving average of $18.56. The stock has a market capitalization of $2.54 billion, a PE ratio of 211.77, a price-to-earnings-growth ratio of 5.26 and a beta of 0.76. Privia Health Group has a 52-week low of $15.92 and a 52-week high of $24.30.

Insider Activity at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of Privia Health Group stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the transaction, the chief executive officer now owns 247,771 shares in the company, valued at approximately $4,583,763.50. The trade was a 35.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 14.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Privia Health Group

Institutional investors and hedge funds have recently bought and sold shares of the business. Canada Pension Plan Investment Board bought a new position in shares of Privia Health Group in the second quarter worth about $26,000. GAMMA Investing LLC grew its holdings in Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after buying an additional 845 shares in the last quarter. Nisa Investment Advisors LLC raised its position in shares of Privia Health Group by 107.5% during the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after buying an additional 930 shares during the last quarter. Signaturefd LLC lifted its holdings in shares of Privia Health Group by 46.3% in the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after buying an additional 626 shares in the last quarter. Finally, Quarry LP boosted its position in shares of Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after acquiring an additional 2,533 shares during the last quarter. 94.48% of the stock is owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.